Total body irradiation is a crucial risk factor for developing
secondary carcinomas after allogeneic hematopoietic stem cell
transplantation in childhood

J 2020

Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood

KESLOVÁ, Petra, R. FORMANKOVA, P. RIHA, L. SRAMKOVA, M. SNAJDEROVA et. al.

Základní údaje

Originální název

Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood

Autoři

KESLOVÁ, Petra (203 Česká republika, garant), R. FORMANKOVA (203 Česká republika), P. RIHA (203 Česká republika), L. SRAMKOVA (203 Česká republika), M. SNAJDEROVA (203 Česká republika), B. MALINOVA (203 Česká republika), A. LUKS (203 Česká republika), Jaroslav ŠTĚRBA (203 Česká republika, domácí), J. STARY (203 Česká republika) a P. SEDLACEK (203 Česká republika)

Vydání

Neoplasma, Bratislava, Slovenská akademie vied, 2020, 0028-2685

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Slovensko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.575

Kód RIV

RIV/00216224:14110/20:00117115

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.4149/neo_2020_200214N131

UT WoS

000576238800022

Klíčová slova anglicky

total body irradiation; secondary carcinoma; allogeneic hematopoietic stem cell transplantation; childhood; risk factor; chronic graft versus host disease

Štítky

14110321, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 11. 2. 2021 08:30, Mgr. Tereza Miškechová

Anotace

V originále

Allogeneic hematopoietic stem cell transplantation (HSCT) has become a standard part of therapy for a variety of malignant and non-malignant disorders. With improved outcomes after HSCT, increasing attention has been drawn to late complications in long-term survivors. The development of secondary malignancies is recognized as one of the most serious complications. We have evaluated data from 426 patients (272 males, 154 females) who underwent allogeneic transplantation at a median age of 7.9 years from 1989 till 2017 and were alive more than one year after transplantation for the occurrence of secondary solid tumors. We have documented the occurrence of secondary solid tumors in 20 patients (4.7%). The median duration of the development of secondary solid cancer from HSCT was 11.7 (range, 5.4-21.5 years). 18 out of 20 patients (90%) had total body irradiation (TBI) 12-14.4 Gy as a part of a conditioning regimen. All but two had transplantation for malignant disease. All patients underwent surgery and/or chemo-radiotherapy. Eighteen are alive, and two died due to the progression of their secondary malignancy. The most frequent solid cancer was thyroid carcinoma (n=9). Cumulative incidence of secondary solid cancer in all groups was 15.2 +/- 3.9%, in a group using TBI based regimen 34.7 +/- 8.9%, in non-TBI (only chemo) group was 1.5 +/- 1.1%. Overall, the cumulative incidence is statistically significantly different between the TBI based and non-TBI (chemo only) group. The incidence and number of complications following allogeneic HSCT in childhood are increasing in time. The early diagnosis of secondary malignancies is one of the key tasks of long-life multidisciplinary post-transplant care.

Citovat

KESLOVÁ, Petra, R. FORMANKOVA, P. RIHA, L. SRAMKOVA, M. SNAJDEROVA, B. MALINOVA, A. LUKS, Jaroslav ŠTĚRBA, J. STARY a P. SEDLACEK. Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood. Neoplasma. Bratislava: Slovenská akademie vied, 2020, roč. 67, č. 5, s. 1164-1169. ISSN 0028-2685. Dostupné z: https://dx.doi.org/10.4149/neo_2020_200214N131.

@article{1699963,
   author = {Keslová, Petra and Formankova, R. and Riha, P. and Sramkova, L. and Snajderova, M. and Malinova, B. and Luks, A. and Štěrba, Jaroslav and Stary, J. and Sedlacek, P.},
   article_location = {Bratislava},
   article_number = {5},
   doi = {http://dx.doi.org/10.4149/neo_2020_200214N131},
   keywords = {total body irradiation; secondary carcinoma; allogeneic hematopoietic stem cell transplantation; childhood; risk factor; chronic graft versus host disease},
   language = {eng},
   issn = {0028-2685},
   journal = {Neoplasma},
   title = {Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood},
   url = {http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=6821&category_id=160&option=com_virtuemart&vmcchk=1&Itemid=1},
   volume = {67},
   year = {2020}
}

TY  - JOUR
ID  - 1699963
AU  - Keslová, Petra - Formankova, R. - Riha, P. - Sramkova, L. - Snajderova, M. - Malinova, B. - Luks, A. - Štěrba, Jaroslav - Stary, J. - Sedlacek, P.
PY  - 2020
TI  - Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood
JF  - Neoplasma
VL  - 67
IS  - 5
SP  - 1164-1169
EP  - 1164-1169
PB  - Slovenská akademie vied
SN  - 00282685
KW  - total body irradiation
KW  - secondary carcinoma
KW  - allogeneic hematopoietic stem cell transplantation
KW  - childhood
KW  - risk factor
KW  - chronic graft versus host disease
UR  - http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=6821&category_id=160&option=com_virtuemart&vmcchk=1&Itemid=1
L2  - http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=6821&category_id=160&option=com_virtuemart&vmcchk=1&Itemid=1
N2  - Allogeneic hematopoietic stem cell transplantation (HSCT) has become a standard part of therapy for a variety of malignant and non-malignant disorders. With improved outcomes after HSCT, increasing attention has been drawn to late complications in long-term survivors. The development of secondary malignancies is recognized as one of the most serious complications. We have evaluated data from 426 patients (272 males, 154 females) who underwent allogeneic transplantation at a median age of 7.9 years from 1989 till 2017 and were alive more than one year after transplantation for the occurrence of secondary solid tumors. We have documented the occurrence of secondary solid tumors in 20 patients (4.7%). The median duration of the development of secondary solid cancer from HSCT was 11.7 (range, 5.4-21.5 years). 18 out of 20 patients (90%) had total body irradiation (TBI) 12-14.4 Gy as a part of a conditioning regimen. All but two had transplantation for malignant disease. All patients underwent surgery and/or chemo-radiotherapy. Eighteen are alive, and two died due to the progression of their secondary malignancy. The most frequent solid cancer was thyroid carcinoma (n=9). Cumulative incidence of secondary solid cancer in all groups was 15.2 +/- 3.9%, in a group using TBI based regimen 34.7 +/- 8.9%, in non-TBI (only chemo) group was 1.5 +/- 1.1%. Overall, the cumulative incidence is statistically significantly different between the TBI based and non-TBI (chemo only) group. The incidence and number of complications following allogeneic HSCT in childhood are increasing in time. The early diagnosis of secondary malignancies is one of the key tasks of long-life multidisciplinary post-transplant care.
ER  -

KESLOVÁ, Petra, R. FORMANKOVA, P. RIHA, L. SRAMKOVA, M. SNAJDEROVA, B. MALINOVA, A. LUKS, Jaroslav ŠTĚRBA, J. STARY a P. SEDLACEK. Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood. \textit{Neoplasma}. Bratislava: Slovenská akademie vied, 2020, roč.~67, č.~5, s.~1164-1169. ISSN~0028-2685. Dostupné z: https://dx.doi.org/10.4149/neo\_{}2020\_{}200214N131.

Podrobný výpis o publikaci